|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001563,
umls-concept:C0022341,
umls-concept:C0030193,
umls-concept:C0030705,
umls-concept:C0065197,
umls-concept:C0149521,
umls-concept:C0205178,
umls-concept:C0231491,
umls-concept:C0597357,
umls-concept:C0699795,
umls-concept:C1261322,
umls-concept:C1261512,
umls-concept:C1304680,
umls-concept:C1516634,
umls-concept:C2603343
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-7-19
|
|
pubmed:abstractText |
Cholecystokinin (CCK)-receptor antagonists have been found to markedly reduce the severity of pancreatitis and improve survival in experimental animal models of acute pancreatitis. CCK appears to play an important role in the development and progression of acute pancreatitis, and the recent development of CCK antagonists has provided a new approach to the treatment of acute pancreatitis in humans.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0885-3177
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e1-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12131781-Acute Disease,
pubmed-meshheading:12131781-Administration, Oral,
pubmed-meshheading:12131781-Adult,
pubmed-meshheading:12131781-Amylases,
pubmed-meshheading:12131781-Chronic Disease,
pubmed-meshheading:12131781-Female,
pubmed-meshheading:12131781-Hormone Antagonists,
pubmed-meshheading:12131781-Humans,
pubmed-meshheading:12131781-Lipase,
pubmed-meshheading:12131781-Male,
pubmed-meshheading:12131781-Middle Aged,
pubmed-meshheading:12131781-Pain,
pubmed-meshheading:12131781-Pancreatitis,
pubmed-meshheading:12131781-Proglumide,
pubmed-meshheading:12131781-Receptor, Cholecystokinin A,
pubmed-meshheading:12131781-Receptors, Cholecystokinin,
pubmed-meshheading:12131781-Treatment Outcome,
pubmed-meshheading:12131781-Trypsin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan.
|
|
pubmed:affiliation |
Department of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan. tskeiko@ige.tmmu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
